Total Payments
$31,806
2023 Payments
$1,270
Companies
7
Transactions
40
Payment Breakdown by Category
Travel$22,514 (70.8%)
Consulting$7,000 (22.0%)
Research$1,712 (5.4%)
Food & Beverage$579.07 (1.8%)
Education$1.47 (0.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $22,514 | 21 | 70.8% |
| Consulting Fee | $7,000 | 2 | 22.0% |
| Unspecified | $1,712 | 3 | 5.4% |
| Food and Beverage | $579.07 | 13 | 1.8% |
| Education | $1.47 | 1 | 0.0% |
Payments by Type
General
$30,094
37 transactions
Research
$1,712
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $17,773 | 11 | $0 (2020) |
| Bayer HealthCare Pharmaceuticals Inc. | $7,944 | 13 | $0 (2020) |
| Celgene Corporation | $2,357 | 3 | $0 (2018) |
| AstraZeneca UK Limited | $1,960 | 9 | $0 (2020) |
| PFIZER INC. | $1,270 | 2 | $0 (2023) |
| Eli Lilly and Company | $442.05 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $60.48 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $1,270 | 2 | PFIZER INC. ($1,270) |
| 2020 | $5,135 | 13 | E.R. Squibb & Sons, L.L.C. ($3,000) |
| 2019 | $7,738 | 10 | Bayer HealthCare Pharmaceuticals Inc. ($7,738) |
| 2018 | $2,448 | 4 | Celgene Corporation ($2,357) |
| 2017 | $15,215 | 11 | E.R. Squibb & Sons, L.L.C. ($14,773) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2023 | PFIZER INC. | — | — | In-kind items and services | $940.00 | Research |
| Study: PALBOCICLIB CLINICAL PUBLICATION PROGRAM | ||||||
| 06/14/2023 | PFIZER INC. | — | — | In-kind items and services | $330.00 | Research |
| Study: PALBOCICLIB CLINICAL PUBLICATION PROGRAM | ||||||
| 07/27/2020 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| 03/10/2020 | AstraZeneca Pharmaceuticals LP | — | Travel and Lodging | Cash or cash equivalent | $60.48 | General |
| 02/03/2020 | AstraZeneca UK Limited | — | Travel and Lodging | In-kind items and services | $957.47 | General |
| 02/03/2020 | AstraZeneca UK Limited | — | Travel and Lodging | In-kind items and services | $305.45 | General |
| 02/03/2020 | AstraZeneca UK Limited | — | Travel and Lodging | In-kind items and services | $269.30 | General |
| 02/03/2020 | AstraZeneca UK Limited | — | Travel and Lodging | In-kind items and services | $199.94 | General |
| 02/03/2020 | AstraZeneca UK Limited | — | Travel and Lodging | In-kind items and services | $132.00 | General |
| 02/03/2020 | AstraZeneca UK Limited | — | Food and Beverage | In-kind items and services | $52.35 | General |
| 02/03/2020 | AstraZeneca UK Limited | — | Food and Beverage | In-kind items and services | $17.39 | General |
| 02/03/2020 | AstraZeneca UK Limited | — | Food and Beverage | In-kind items and services | $15.41 | General |
| 02/03/2020 | AstraZeneca UK Limited | — | Food and Beverage | In-kind items and services | $10.43 | General |
| 01/27/2020 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug) | Travel and Lodging | In-kind items and services | $71.35 | General |
| Category: Oncology | ||||||
| 01/27/2020 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $43.86 | General |
| Category: Oncology | ||||||
| 10/03/2019 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug) | Travel and Lodging | In-kind items and services | $212.78 | General |
| Category: Oncology | ||||||
| 10/03/2019 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug) | Travel and Lodging | In-kind items and services | $127.30 | General |
| Category: Oncology | ||||||
| 10/03/2019 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $84.09 | General |
| Category: Oncology | ||||||
| 10/03/2019 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug) | Travel and Lodging | In-kind items and services | $70.93 | General |
| Category: Oncology | ||||||
| 09/12/2019 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug) | Travel and Lodging | In-kind items and services | $6,036.93 | General |
| Category: Oncology | ||||||
| 06/07/2019 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug) | Travel and Lodging | In-kind items and services | $60.00 | General |
| Category: Oncology | ||||||
| 01/10/2019 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug) | Food and Beverage | In-kind items and services | $124.32 | General |
| Category: Oncology | ||||||
| 01/09/2019 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug) | Travel and Lodging | In-kind items and services | $141.60 | General |
| Category: Oncology | ||||||
| 01/09/2019 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug) | Travel and Lodging | In-kind items and services | $119.10 | General |
| Category: Oncology | ||||||
| 01/02/2019 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug) | Travel and Lodging | In-kind items and services | $761.00 | General |
| Category: Oncology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PALBOCICLIB CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $1,270 | 2 |
| A PHASE 1, OPEN-LABEL, DOSE-ESCALATION STUDY OF OLARATUMAB AS A SINGLE AGENT AND IN COMBINATION WITH DOXORUBICIN, VINCRISTINE/IRINOTECAN, OR HIGH-DOSE IFOSFAMIDE IN PEDIATRIC PATIENTS WITH RELAPSED OR REFRACTORY SOLID TUMORS | Eli Lilly and Company | $442.05 | 1 |
About Douglas Hawkins
Douglas Hawkins is a Pediatric Hematology-Oncology healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265522155.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Douglas Hawkins has received a total of $31,806 in payments from pharmaceutical and medical device companies, with $1,270 received in 2023. These payments were reported across 40 transactions from 7 companies. The most common payment nature is "Travel and Lodging" ($22,514).
Ad
Practice Information
- Specialty Pediatric Hematology-Oncology
- Location Seattle, WA
- Active Since 10/13/2006
- Last Updated 07/08/2007
- Taxonomy Code 2080P0207X
- Entity Type Individual
- NPI Number 1265522155
Products in Payments
- Stivarga (Drug) $6,647
- Vitrakvi (Drug) $1,206
- Non-Covered $90.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Hematology-Oncology Doctors in Seattle
Dr. Rachel Rau, Md, MD
Pediatric Hematology-Oncology — Payments: $68,797
Pediatric Hematology-Oncology $68,797
Dr. Paul Carpenter
Pediatric Hematology-Oncology — Payments: $35,523
Pediatric Hematology-Oncology $35,523
Rebecca Gardner, Md, MD
Pediatric Hematology-Oncology — Payments: $20,740
Pediatric Hematology-Oncology $20,740
Soheil Meshinchi, Md,Phd, MD,PHD
Pediatric Hematology-Oncology — Payments: $17,418
Pediatric Hematology-Oncology $17,418
Dr. Navin Pinto, M.d, M.D
Pediatric Hematology-Oncology — Payments: $9,804
Pediatric Hematology-Oncology $9,804
Dr. Michael Bender, M.d. , Phd, M.D. , PHD
Pediatric Hematology-Oncology — Payments: $7,865
Pediatric Hematology-Oncology $7,865